SNWV insider transaction filings
SANUWAVE Health, Inc. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-04. Screen SNWV transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-04 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 24,000 @ $16.15 · Sale (S): 1,000 @ $16.15 · Sale (S): 10,081 @ $16.11 · Sale (S): 500 @ $16.11 | EDGAR |
| 2026-04-30 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 43,788 @ $18.47 · Sale (S): 2,500 @ $18.47 · Sale (S): 23,360 @ $17.25 · Sale (S): 1,000 @ $17.25 | EDGAR |
| 2026-04-21 | 4 | Opaleye Management Inc. — 10% owner | Sale (S): 11,267 @ $20.46 · Sale (S): 5,000 @ $20.46 · Sale (S): 202 @ $20.50 | EDGAR |
| 2025-12-15 | 4 | MANCHESTER MANAGEMENT CO LLC Manchester Explorer, L.P. FRANK MORGAN C. — 10% owner BESSER JAMES E MANCHESTER MANAGEMENT PR, LLC | Sale (S): 13,500 @ $31.28 · Sale (S): 6,500 @ $21.04 | EDGAR |
| 2025-12-11 | 4/A | MANCHESTER MANAGEMENT CO LLC Manchester Explorer, L.P. MANCHESTER MANAGEMENT PR, LLC FRANK MORGAN C. — 10% owner BESSER JAMES E | Sale (S): 125,400 @ $30.75 · Sale (S): 8,785 @ $30.58 · Sale (S): 8,625 @ $30.39 · Sale (S): 2,000 @ $31.60 | EDGAR |
| 2025-12-10 | 4 | MANCHESTER MANAGEMENT CO LLC Manchester Explorer, L.P. MANCHESTER MANAGEMENT PR, LLC FRANK MORGAN C. — 10% owner BESSER JAMES E | Sale (S): 125,400 @ $30.75 · Sale (S): 8,785 @ $30.58 · Sale (S): 8,625 @ $30.39 · Sale (S): 2,000 @ $31.60 | EDGAR |
| 2025-10-09 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 1,267 @ $30.28 | EDGAR |
| 2025-07-02 | 4 | Tyler James — Director | Grant/award (A): 1,574 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Blizard Jeffrey — Director | Grant/award (A): 1,574 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Bazar Gregory Matthew — Director | Grant/award (A): 1,574 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Miller Ian D. — Director | Grant/award (A): 1,771 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | FRANK MORGAN C. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,574 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Stolarski Anthony Michael — Director | Conversion (C): 103,114 @ $15 · Conversion (C): 6,900 @ $15 · Grant/award (A): 80,698 · Grant/award (A): 76,215 · Grant/award (A): 5,400 · Grant/award (A): 5,100 · +30 more | EDGAR |
| 2025-06-09 | 4 | Stegagno Peter — Chief Operating Officer | Option exercise (M): 529 @ $22.50 · Option exercise (M): 1,333 @ $15 · Sale (S): 1,862 @ $27.71 · Option exercise (M): 529 (derivative) @ $0 · Option exercise (M): 1,333 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Bazar Gregory Matthew — Director | Grant/award (A): 41,333 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Cioanta Iulian — Chief Sci. and Tech. Officer | Option exercise (M): 1,777 @ $14.20 · Option exercise (M): 529 @ $22.50 · Option exercise (M): 1,333 @ $15 · Sale (S): 3,639 @ $31.60 · Option exercise (M): 1,777 (derivative) @ $0 · Option exercise (M): 529 (derivative) @ $0 · +1 more | EDGAR |
| 2025-04-30 | 4 | Opaleye Management Inc. — 10% owner | Purchase (P): 5,000 @ $25.49 · Purchase (P): 2,998 @ $25.49 | EDGAR |
| 2025-04-07 | 4 | Tyler James — Director | Grant/award (A): 1,761 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Blizard Jeffrey — Director | Grant/award (A): 1,761 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Miller Ian D. — Director | Grant/award (A): 1,981 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | FRANK MORGAN C. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,761 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Stegagno Peter — Chief Operating Officer | Grant/award (A): 885 · Grant/award (A): 1,141 · Grant/award (A): 885 (derivative) @ $0.00 · Disposition to issuer (D): 885 (derivative) @ $0 · Grant/award (A): 885 (derivative) @ $0 · Disposition to issuer (D): 885 (derivative) @ $0 · +16 more | EDGAR |
| 2025-03-24 | 4 | Miller Ian D. — Director | Grant/award (A): 8,050 @ $15 · Grant/award (A): 3,833 @ $15 · Grant/award (A): 6,300 · Grant/award (A): 5,950 · Grant/award (A): 3,000 · Grant/award (A): 2,834 · +14 more | EDGAR |
| 2025-03-18 | 4 | Blizard Jeffrey — Director | Grant/award (A): 41,333 (derivative) @ $0 · Grant/award (A): 1,559 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Tyler James — Director | Conversion (C): 3,450 @ $15 · Grant/award (A): 2,700 · Grant/award (A): 2,550 · Grant/award (A) @ $45,000 · Conversion (C) @ $0 · Grant/award (A): 3,000 (derivative) · +5 more | EDGAR |
| 2025-02-21 | 4 | FRANK MORGAN C. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | FRANK MORGAN C. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 138,874 (derivative) @ $0 · Grant/award (A): 21,126 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | FRANK MORGAN C. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,559 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Gilmore Nanci — Chief Commercial Officer | Grant/award (A): 1,571 (derivative) @ $15.67 | EDGAR |
| 2025-02-07 | 4 | Sorensen Peter — Chief Financial Officer | Grant/award (A): 260 (derivative) @ $15.67 | EDGAR |
| 2025-01-28 | 4 | Wern David Timothy — Executive VP of Sales | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — SANUWAVE Health, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | EDGAR |
| 2026-01-15 | 8-K/A | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SNWV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →